The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 first-in-human clinical trial of AG01, a recombinant monoclonal antibody to progranulin/glycoprotein 88 (PGRN/GP88), to determine the safety, tolerability, pharmacokinetics, and preliminary anti-tumor response in subjects with advanced solid tumor malignancies.
 
Katherine Tkaczuk
Research Funding - AstraZeneca (Inst); Genentech (Inst); Gilead Sciences (Inst); Merck (Inst); Olema Oncology (Inst); Porcessa (Inst); SynDevRx (Inst); Vaxiion Therapeutics (Inst)
 
Paula Rosenblatt
Research Funding - AstraZeneca (Inst); Merck Sharp & Dohme (Inst)
 
Katherine Scilla
Honoraria - OncLive/MJH Life Sciences
Research Funding - AstraZeneca (Inst); Merck (Inst); Teligene (Inst); Turning Point Therapeutics (Inst)
 
Ranee Mehra
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Consulting or Advisory Role - Coherus Biosciences; Janssen Oncology; Merck KGaA
Research Funding - AstraZeneca; Merck
Travel, Accommodations, Expenses - Merck KGaA
(OPTIONAL) Uncompensated Relationships - AstraZeneca
 
Yixing Jiang
Honoraria - Cardinal Health
Consulting or Advisory Role - Innovative cell therapy
Research Funding - white oak
 
Petr Hausner
Research Funding - ICON Oncology (Inst); PAREXEL (Inst)
 
Gautham Rao
No Relationships to Disclose
 
Nancy Tait
No Relationships to Disclose
 
Binbin Yue
Employment - AGPharma Inc
 
Ginette Serrero
Employment - A&G Pharmaceutical
Leadership - A&G Pharmaceutical